These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors. Ibrar A, Tehseen Y, Khan I, Hameed A, Saeed A, Furtmann N, Bajorath J, Iqbal J. Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072 [Abstract] [Full Text] [Related]
4. Identification of a new class of potent aldose reductase inhibitors: Design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines. Sever B, Altıntop MD, Demir Y, Yılmaz N, Akalın Çiftçi G, Beydemir Ş, Özdemir A. Chem Biol Interact; 2021 Aug 25; 345():109576. PubMed ID: 34252406 [Abstract] [Full Text] [Related]
5. Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5-c]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase. Crespo I, Giménez-Dejoz J, Porté S, Cousido-Siah A, Mitschler A, Podjarny A, Pratsinis H, Kletsas D, Parés X, Ruiz FX, Metwally K, Farrés J. Eur J Med Chem; 2018 May 25; 152():160-174. PubMed ID: 29705708 [Abstract] [Full Text] [Related]
6. A new series of hydrazones as small-molecule aldose reductase inhibitors. Altıntop MD, Demir Y, Türkeş C, Öztürk RB, Cantürk Z, Beydemir Ş, Özdemir A. Arch Pharm (Weinheim); 2023 Apr 25; 356(4):e2200570. PubMed ID: 36603162 [Abstract] [Full Text] [Related]
12. Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study. Shehzad MT, Imran A, Njateng GSS, Hameed A, Islam M, Al-Rashida M, Uroos M, Asari A, Shafiq Z, Iqbal J. Bioorg Chem; 2019 Jun 25; 87():857-866. PubMed ID: 30551808 [Abstract] [Full Text] [Related]
13. Novel acetic acid derivatives containing quinazolin-4(3H)-one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors. Tokalı FS, Demir Y, Türkeş C, Dinçer B, Beydemir Ş. Drug Dev Res; 2023 Apr 25; 84(2):275-295. PubMed ID: 36598092 [Abstract] [Full Text] [Related]
15. Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors. Wu B, Yang Y, Qin X, Zhang S, Jing C, Zhu C, Ma B. ChemMedChem; 2013 Dec 25; 8(12):1913-7. PubMed ID: 24115741 [Abstract] [Full Text] [Related]
16. Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation. Imran A, Tariq Shehzad M, Al Adhami T, Miraz Rahman K, Hussain D, Alharthy RD, Shafiq Z, Iqbal J. Bioorg Chem; 2021 Oct 25; 115():105164. PubMed ID: 34314916 [Abstract] [Full Text] [Related]
17. Structure-based optimization of aldose reductase inhibitors originating from virtual screening. Eisenmann M, Steuber H, Zentgraf M, Altenkämper M, Ortmann R, Perruchon J, Klebe G, Schlitzer M. ChemMedChem; 2009 May 25; 4(5):809-19. PubMed ID: 19301313 [Abstract] [Full Text] [Related]